An amplicon-based liquid biopsy for detecting ALK and ROS1 fusions and resistance mutations in advanced non-small cell lung cancer (NSCLC) patients.
暂无分享,去创建一个
D. Planchard | V. Plagnol | J. Adam | C. Caramella | L. Lacroix | B. Besse | L. Mezquita | E. Rouleau | K. Howarth | N. Auger | G. Recondo | F. Farace | L. Friboulet | C. Morris | E. Auclin | C. Nicotra | C. Jovelet | E. Green | E. Pailler